Fundamental mechanisms of action of calcium antagonists in myocardial ischemia

This publication has 37 references indexed in Scilit:

• Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury
  Journal of Molecular and Cellular Cardiology, 1986
• Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment
  The American Journal of Cardiology, 1985
• The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs
  American Heart Journal, 1985
• Protection by verapamil of globally ischemic rat hearts: Energy preservation, a partial explanation
  Journal of Molecular and Cellular Cardiology, 1985
• Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.
  Circulation, 1984
• Verapamil in acute myocardial infarction
  European Heart Journal, 1984
• Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
  Circulation, 1984
• The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart
  Journal of Molecular and Cellular Cardiology, 1980
• Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium
  The American Journal of Cardiology, 1980
• Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion
  Journal of Molecular and Cellular Cardiology, 1980